Rogers Michael P, DeSantis Anthony J, DuCoin Christopher G
Department of Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL 33606, USA.
Department of Surgery, Division of Gastrointestinal Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL 33606, USA.
Cancers (Basel). 2021 Aug 28;13(17):4352. doi: 10.3390/cancers13174352.
Esophageal adenocarcinoma is an aggressive cancer of increasing incidence and is associated with poor prognosis. The early recognition of synchronous and metachronous oligometastasis in esophageal adenocarcinoma may allow for prompt intervention and potentially improved survival. However, curative approaches to oligometastatic esophageal disease remain unproven and may represent an area of emerging divergence of opinion for surgical and medical oncologists. We sought to identify the current understanding and evidence for management of oligometastatic esophageal adenocarcinoma by performing a thorough review of the available literature.
食管腺癌是一种侵袭性癌症,发病率不断上升,预后较差。早期识别食管腺癌中的同时性和异时性寡转移可能有助于及时干预并 potentially 提高生存率。然而,针对寡转移食管疾病的根治性方法仍未得到证实,可能是外科肿瘤学家和医学肿瘤学家意见出现分歧的一个新领域。我们试图通过全面回顾现有文献来确定目前对寡转移食管腺癌治疗的认识和证据。